TITLE

The new millennium: applying novel technology to the study of the cancer cell in situ

AUTHOR(S)
Brown, Monica R.; Kohn, Elise C.; Hutter, Robert V. P.
PUB. DATE
December 2000
SOURCE
European Journal of Nuclear Medicine;2000 Supplement, Vol. 27 Issue 13, ps27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Deals with the application of technology to the study of cancer. Uses of the knowledge gained in cancer biology; Advances in technology in the study of cancer; Adaptation of laser technology to molecular pathology.
ACCESSION #
4738839

 

Related Articles

  • Ovarian cancer molecular pathology. Longuespée, Rémi; Boyon, C.; Desmons, Annie; Vinatier, Denis; Leblanc, Eric; Farré, Isabelle; Wisztorski, Maxence; Ly, Kévin; D'Anjou, François; Day, Robert; Fournier, Isabelle; Salzet, Michel // Cancer & Metastasis Reviews;Dec2012, Vol. 31 Issue 3/4, p713 

    Ovarian cancer (OVC) is the fourth leading cause of cancer mortality among women in Europe and the United States. Its early detection is difficult due to the lack of specificity of clinical symptoms. Unfortunately, late diagnosis is a major contributor to the poor survival rates for OVC, which...

  • Urothelial Carcinoma. Chow, Nan-Haw; Knowles, Margaret; Bivalacqua, Trinity J. // Advances in Urology;2012, p1 

    An introduction for the articles published in the issue is presented which incorporates several topics including molecular pathogenesis, bladder cancer and using oncolytic viruses in cancer treatment.

  • Impact of race/ethnicity on molecular pathways in human cancer. Wiencke, John K. // Nature Reviews Cancer;Jan2004, Vol. 4 Issue 1, p79 

    Studies the impact of race/ethnicity on molecular pathways in human cancer. Definition of race; Epidemiological evidence that self-identified race/ethnicity is associated with differences in cancer incidence and mortality; Ancestry and racial categories.

  • Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Shuji Ogino // Gut;Mar2011, Vol. 60 Issue 3, p397 

    Colorectal cancer is a complex disease resulting from somatic genetic and epigenetic alterations, including locus-specific CpG island methylation and global DNA or LINE-1 hypomethylation. Global molecular characteristics such as microsatellite instability (MSI), CpG island methylator phenotype...

  • Differences in Molecular Pathologic Characteristics of Pancreatic Adenocarcinoma between Egyptian and Moroccan Patients. Robinson, Sara; Soliman, Amr S.; Karkouri, Mehdi; Omer, Hoda Gad; Greenson, Joel F. // Middle East Journal of Cancer;2010, Vol. 1 Issue 1, p27 

    Introduction: Pancreatic cancer has not been well studied, especially in developing countries. Materials and Methods: We studied the variations in genetic mutations in pancreatic adenocarcinoma between Moroccan and Egyptian populations. The molecular pathology of 30 tumors from a large hospital...

  • Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation. Rahman, M M; Qian, Z R; Wang, E L; Sultana, R; Kudo, E; Nakasono, M; Hayashi, T; Kakiuchi, S; Sano, T // British Journal of Cancer;2/10/2009, Vol. 100 Issue 3, p501 

    The molecular pathogenesis of gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) remains to be elucidated. High-mobility group A (HMGA) proteins play important roles in the regulation of transcription, differentiation, and neoplastic transformation. In this study, the expression of HMGA1...

  • Mucinous Adenocarcinoma of Bartholin Gland Treated with Radiation Therapy: a Case Report. Ohno, Tatsuya; Nakano, Takashi; Abe, Atsuko; Sano, Takaaki; Niibe, Yuzuru; Oka, Kuniyuki // Japanese Journal of Clinical Oncology;May2001, Vol. 31 Issue 5, p226 

    Discusses the molecular pathological features of adenocarcinoma of Bartholin gland. Case study of an elderly woman with mucinous adenocarcinoma of Bartholin gland with metastasis to the right inguinal lymph node; Presence of human papillomavirus 16 and 18 DNA; Expression of p53 protein.

  • AMP optimistic in suit to invalidate patents on breast cancer genes.  // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1 

    The article informs that Association for Molecular Pathology (AMP) is optimistic about invalidating the patents on breast cancer genes in the lawsuit filed against AMP and Myriad Genetics Inc.

  • Molecular Pathogenesis of Malignant Glial Tumors. Jones, Terreia S.; Holland, Eric C. // Toxicologic Pathology;1/1/2011, Vol. 39 Issue 1, p158 

    Malignant glial tumors are the most aggressive and difficult to treat neoplasms arising in the brain. More than 22,000 people in the United States are diagnosed with a malignant glioma annually, and most will die within the first two years from diagnosis. Traditionally, gliomas have been...

  • New approaches to molecular cancer therapeutics. Collins, Ian; Workman, Paul // Nature Chemical Biology;Dec2006, Vol. 2 Issue 12, p689 

    Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop 'personalized' medicine. The new paradigm is to develop agents that target the precise molecular pathology driving the progression of individual cancers. Drug developers have...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics